Abstract
We report a case of a 70-year-old man with dermatomyositis complicated by esophageal involvement resistant to corticosteroid therapy. It had serious and potentially life-threatening implications, resulting in impossible oral feeding. This condition was successfully resolved by administration of cyclosporine A.
References
Marie I, Hatron PY, Hachulla E, Wallaert B, Michon-Pasturel U, Devulder B (1998) Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol 25:1336–1343
Marie I, Hatron PY, Levesque H, Hachulla E, Hellot MF, Michon-Pasturel U et al (1999) Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore) 18:139–147
Sonies BC (1997) Evaluation and treatment of speech and swallowing disorders associated with myopathies. Curr Opin Rheumatol 9:486–495
Carpenter JR, Bunch TW, Engel AG, O’Brien PC (1977) Survival in polymyositis: corticosteroids and risk factors. J Rheumatol 4:207–214
Dalakas MC (1994) Current treatment of inflammatory myopathies. Curr Opin Rheumatol 5:595–601
Dalakas MC (1995) Update of the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease. J Clin Immunol 15:70S–75S
Herson S, Cherin P, Coutellier A (1992) The association of plasma exchange synchronized with intravenous gamma globulin therapy in severe intractable polymyositis. J Rheumatol 19:828–829
Matsubara S, Hirai S, Sawa Y (1997) Pulsed intravenous methylprednisolone therapy for inflammatory myopathies: evaluation of the effect by comparing two consecutive biopsies from the same muscle. J Neuroimmunol 76:75–80
Villalba L, Adams EM (1996) Update of therapy for refractory dermatomyositis and polymyositis. Curr Opin Rheumatol 8:544–551
Marie I, Hachulla E, Levesque H, Reumont G, Ducrotte P, Cailleux N et al (1999) Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis. J Rheumatol 26:2706–2709
Yocum DE (1996) Cyclosporine, FK-506, rapamycin, and other immunomodulators. Rheum Dis Clinics North Am 22:133–154
Miller FW (1998) Myositis and myopathies [editorial]. Curr Opin Rheumatol 10:499–503
Kaye SB (1998) Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention. Curr Opin Oncol 10(suppl 1):S15–S19
Meijer OC, De Lange ECM, Breimer DD, De Boer AG, Workel JO, De Kloet ER (1998) Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1a P-glycoprotein knockout mice. Endocrinology 139:1789–1793
Mckeegan KS, Borges-Walmsley MI, Walmsley AR (2003) The structure and function of drug pumps: an update. Trends Microbiol 11:21–29
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mii, S., Niiyama, S., Kusunoki, M. et al. Cyclosporine A as treatment of esophageal involvement in dermatomyositis. Rheumatol Int 27, 183–185 (2006). https://doi.org/10.1007/s00296-006-0168-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-006-0168-6